A clinical trial to study the effect of two drugs ropivacaine and levobupivacaine in labor pain relief by dural puncture epidural technique
Phase 4
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2019/01/017099
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA I and ASA II parturient having single fetus in vertex presentation
2. Patients in active labor with cervical dilatation <5.0 cm
3. Patients desiring labor analgesia
Exclusion Criteria
1. Patients refusal to participate
2. Patients with diseases of pregnancy such as gestational hypertension, preeclampsia, gestational diabetes mellitus
3. Patients in whom neuraxial procedures are contraindicated
4. Patients having fetus with anomalies
5. Patients who are at high chance for cesarean delivery such as cephalopelvic disproportion, previous cesarean section
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of onset to NPRS score â?¤ 1Timepoint: 0.5,2,4,6,8,10,12,14,16,18,20 and 30 minutes, then every 90 minutes until delivery
- Secondary Outcome Measures
Name Time Method 1. Symmetry of blockade <br/ ><br>2. Maternal adverse effects such as pruritus, hypotension, uterine tachysystole and hypertonus <br/ ><br>3. Time to delivery <br/ ><br>4. Mode of delivery <br/ ><br>5. Fetal outcomes by APGAR <br/ ><br>6. Number of boluses by PCEA <br/ ><br>7. Number of physician top-up interventionsTimepoint: 0.5,2,4,6,8,10,12,14,16,18,20 and 30 minutes, then every 90 minutes until delivery